Home Tags Pharmaceuticals

Tag: Pharmaceuticals

Pay-For-Delay: Who Does the Generic Industry Lobby Represent?

European Commission and National Authorities Take a Stand Against Excessive Pricing...

By: Hendrik Viaene and Karolien Van der Putten (Antitrust Alert) The European Commission and national competition authorities (NCAs) are very actively fighting a number of anticompetitive practices in...
EU Court of Justice Rules Lundbeck Patent Settlement Agreements

EU Court of Justice Rules on Lundbeck Patent Settlement Agreements

On March 25, 2021, the Court of Justice of the European Union published its judgments in the Lundbeck case. The CJEU dismissed the parties’...
The No Kill Zone: The Other Side of Pharma Acquisitions

The No Kill Zone: The Other Side of Pharma Acquisitions

In recent years there have been calls for increased scrutiny and enforcement of acquisitions by incumbent pharmaceutical firms of potentially competitive pipeline products. A...
Pay-For-Delay: Who Does the Generic Industry Lobby Represent?

Pay-For-Delay: Who Does the Generic Industry Lobby Represent?

The generic industry lobby, Association for Accessible Medicines (“AAM”), often represents the public interest. In the pharmaceutical industry, it challenges brand drug companies’ anticompetitive...
First of All, Do No Harm: New Directions in EU Antitrust Enforcement Regarding Pharmaceuticals

First of All, Do No Harm: New Directions in EU Antitrust...

The recent Paroxetine and CMA v. Pfizer/Flynn cases confirm the EU approach to pay-for-delay, respectively establish a workable approach to excessive pharmaceutical pricing at...
Rethinking Pharmaceutical Product Reformulations

Rethinking Pharmaceutical Product Reformulations

This piece discusses pharmaceutical product reformulations and product hopping strategies, along with the impact that antitrust scrutiny may have on innovation incentives. The main...
pharma pils image

Invoking the ECJ’s Intel Judgment, the UK Court of Appeal Broadly...

By James Killick, Assimakis Komninos & Aqeel Kadri (White & Case LLP)1   Introduction On March 10, 2020, the UK Court of Appeal upheld the Competition Appeal...
Blank Pills

ECJ Ruling on Paroxetine

By James Killick, Marc Israel, Jérémie Jourdan & Aqeel Kadri (White & Case LLP)1 On January 30, 2020 (just sneaking in before Brexit), the European...
Antitrust Enforcement in the Pharmaceuticals and Medical Products Industry in China

Antitrust Enforcement in the Pharmaceuticals and Medical Products Industry in China

B The pharmaceutical and medical products industry in China has seen high levels of antitrust enforcement activity from 2015 onwards. This article takes stock of...
Europills

Paroxetine – The EU Court of Justice Rules on Pay-For-Delay Settlements...

Maria José Schmidt-Kessen (Copenhagen Business School)1   Introduction While we are still awaiting the judgments in the pending appeals on pay-for-delay settlements in Lundbeck2 and Servier,3 the...
Enable Notifications    OK No thanks